CYP3A4/5 and pharmacogenetics in patients with sarcoma - Authors' reply

Lancet Oncol. 2007 Aug;8(8):668-9. doi: 10.1016/S1470-2045(07)70216-4.

Authors

Jay S Wunder¹, Torsten O Nielsen, Robert G Maki, Brian O'sullivan, Benjamin A Alman

Affiliation

¹ University Musculoskeletal Oncology Unit and Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

PMID: 17679079
DOI: 10.1016/S1470-2045(07)70216-4

No abstract available

Publication types

Letter

MeSH terms

Bone Neoplasms / genetics*
Cytochrome P-450 CYP3A
Cytochrome P-450 Enzyme System / genetics*
Genotype
Humans
Pharmacogenetics*
Polymorphism, Single Nucleotide*
Sarcoma / genetics*

Substances

Cytochrome P-450 Enzyme System
CYP3A5 protein, human
Cytochrome P-450 CYP3A
CYP3A4 protein, human